Qulipta
Payments companies reported to CMS as associated with Qulipta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Qulipta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Qulipta
These are the largest totals companies reported as associated with Qulipta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bradley Torphy | Chicago, IL | Family Medicine | $331,790.90 |
| Chaouki Khoury | Atlanta, GA | Neurology With Special Qualifications In Child Neurology | $320,822.12 |
| Andrew Blumenfeld | Carlsbad, CA | Neurology (Psychiatry & Neurology) | $311,337.13 |
| Pankaj Satija | Houston, TX | Neurology (Psychiatry & Neurology) | $302,184.19 |
| Nicolas Saikali | Amherst, NY | Neurology (Psychiatry & Neurology) | $217,525.09 |
| Kavita Kalidas | Lutz, FL | Neurology (Psychiatry & Neurology) | $211,172.49 |
| Anna Kersey | Savannah, TN | Physician Assistant | $210,301.36 |
| Ruwani Gunawardane | Fulton, MD | Neurology (Psychiatry & Neurology) | $209,556.28 |
| Wade Cooper | Ann Arbor, MI | Neurology (Psychiatry & Neurology) | $206,681.55 |
| Christopher Rhyne | Louisville, KY | Family Medicine | $194,663.03 |
Prescribed Qulipta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.